These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25692469)

  • 1. Findings from integrated behavioral and biologic survey among males who inject drugs (MWID) - Vietnam, 2009-2010: evidence of the need for an integrated response to HIV, hepatitis B virus, and hepatitis C virus.
    Nadol P; O'connor S; Duong H; Le LV; Thang PH; Tram TH; Ha HT; Mcconnell MS; Partridge J; Kaldor J; Law M; Nguyen TA
    PLoS One; 2015; 10(2):e0118304. PubMed ID: 25692469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated HIV surveillance finds recent adult hepatitis B virus (HBV) transmission and intermediate HBV prevalence among military in uncharacterized Caribbean country.
    O'Connor SM; Mixson-Hayden T; Ganova-Raeva L; Djibo DA; Brown M; Xia GL; Kamili S; Jacobs M; Dong M; Thomas AG; Bulterys M; Hale B
    PLoS One; 2019; 14(10):e0222835. PubMed ID: 31574098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.
    Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):311-20. PubMed ID: 22828983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England.
    Edeh J; Spalding P
    J Public Health Med; 2000 Dec; 22(4):531-9. PubMed ID: 11192282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
    Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
    Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
    Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
    BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of infection with hepatitis B and C viruses and co-infection with HIV in three jails: a case for viral hepatitis prevention in jails in the United States.
    Hennessey KA; Kim AA; Griffin V; Collins NT; Weinbaum CM; Sabin K
    J Urban Health; 2009 Jan; 86(1):93-105. PubMed ID: 18622707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.
    Ishizaki A; Tran VT; Nguyen CH; Tanimoto T; Hoang HTT; Pham HV; Phan CTT; Bi X; Pham TV; Ichimura H
    PLoS One; 2017; 12(6):e0179616. PubMed ID: 28662105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and correlates of HIV infection among men who inject drugs in a remote area of Vietnam.
    Nghiem VT; Bui TC; Nadol PP; Phan SH; Kieu BT; Kling R; Hammett TM
    Harm Reduct J; 2018 Feb; 15(1):8. PubMed ID: 29444685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks for HIV, HBV, and HCV infections among male injection drug users in northern Vietnam: a case-control study.
    Quan VM; Go VF; Nam le V; Bergenstrom A; Thuoc NP; Zenilman J; Latkin C; Celentano DD
    AIDS Care; 2009 Jan; 21(1):7-16. PubMed ID: 19085215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HIV Prevalence and Associated Risk Factors Among Female Sexual Partners of Male Injection Drug Users (MWID) in Ho Chi Minh City, Vietnam.
    Nadol P; Tran H; Hammett T; Phan S; Nguyen D; Kaldor J; Law M
    AIDS Behav; 2016 Feb; 20(2):395-404. PubMed ID: 26271814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
    Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
    BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infections among people who inject drugs in Kuwait: A cross-sectional study.
    Altawalah H; Essa S; Ezzikouri S; Al-Nakib W
    Sci Rep; 2019 Apr; 9(1):6292. PubMed ID: 31000775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sero-epidemiology of human immunodeficiency virus, hepatitis B virus and hepatitis C virus: a cross-sectional survey in a rural setting of the West region of Cameroon.
    Nansseu JR; Mbogning DM; Monamele GC; Tamoh SF; Gonsu HK; Kouanfack C; Yanwou YN; Sando Z
    Pan Afr Med J; 2017; 28():201. PubMed ID: 29610639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
    Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
    Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Factors of HBV and HCV Co-Infection Among People Living with HIV in an Egyptian Setting.
    El-Ghitany EM; Farghaly AG; Alkassabany YM
    Curr HIV Res; 2021; 19(6):514-524. PubMed ID: 34353267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis.
    Bao Y; Larney S; Peacock A; Colledge S; Grebely J; Hickman M; Degenhardt L; Leung J
    Int J Drug Policy; 2019 Aug; 70():87-93. PubMed ID: 31125802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.